S-1/A: XBP Europe Holdings Files Amendment No. 2 to Form S-1 Registration Statement

Sentiment:

Registration Statement Amendment


XBP Europe Holdings amends its S-1 registration for the potential issuance and resale of common stock and warrants.

Capital raiseThe document discusses the potential issuance of shares upon exercise of warrants, which would result in a capital raise for the company.The document also mentions the potential for the company to raise capital through the sale of shares by selling securityholders.
Worse than expectedThe current market price of the Common Stock is significantly below the exercise price of the Warrants, making it unlikely that the Warrants will be exercised in the near term.The resale of shares by Selling Securityholders could cause a significant decline in the trading price of the Common Stock.

Summary

  • XBP Europe Holdings, Inc. filed Amendment No. 2 to its Form S-1 registration statement with the SEC on February 2, 2024.
  • The prospectus relates to the issuance of up to 6,634,980 shares of common stock upon exercise of warrants.
  • It also covers the offer and sale of up to 27,775,355 shares of common stock by selling securityholders.
  • The selling securityholders include CFAC Holdings VIII, LLC (the Sponsor) and BTC International Holdings, Inc.
  • The Sponsor acquired Founder Shares at approximately $0.005 per share and Promote Forward Purchase Shares for no additional consideration.
  • BTC International acquired shares pursuant to the Merger Agreement at approximately $6.70 per share.
  • The closing price of XBP Europe's Common Stock on January 31, 2024, was $2.26.
  • The Sponsor may experience a potential profit of $2.255 per share for each Founder Share and $2.26 per share for each Promote Forward Purchase Share if sold at $2.26.
  • The registration of these securities does not guarantee that the selling securityholders will offer or sell any shares.
  • The number of shares registered for resale represents approximately 92.1% of the company's outstanding shares, assuming the exercise of the Private Warrants for cash.
  • The resale of these shares could significantly decrease the trading price of the Common Stock.
  • Approximately 91.3% of the shares are subject to resale restrictions until November 29, 2024, subject to limited exceptions.
  • The company will bear the registration expenses and will not receive any proceeds from the sale of shares by the selling securityholders.
  • The exercise price for the Private Warrants and Public Warrants is $11.50 per share.
  • The company is an emerging growth company and is subject to reduced public company reporting requirements.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While it outlines the potential for the company to raise capital, it also highlights the risk of stock price decline due to the resale of shares by selling securityholders and the unlikelihood of warrant exercises in the near term.

Positives

  • The company is registering the securities for resale pursuant to the Selling Securityholders registration rights under certain agreements between us and the Selling Securityholders.

Negatives

  • The resale of the shares of Common Stock pursuant to this prospectus could cause a significant decline on the trading price of the Common Stock, even though not all of the securities covered by this prospectus held by the Selling Securityholders are eligible for immediate resale due to certain lock -up agreements.
  • Given the current market price of our Common Stock, certain of the Selling Securityholders who paid less for their shares than such current market price, or received shares for no cash consideration, will receive a higher rate of return on any such sales than the public securityholders who purchased Common Stock in the IPO.
  • Because the $11.50 exercise price per share of the Warrants is greater than the current market price of our shares of Common Stock, such Warrants are unlikely to be exercised at this time and therefore we do not expect to receive any proceeds from such exercise of the Warrants in the near term.

Risks

  • The number of shares of Common Stock that the Selling Securityholders can sell into the public markets pursuant to this prospectus greatly exceeds the Companys public float.
  • The Selling Securityholders can earn a positive rate of return on their investment in our Common Stock, even if other stockholders experience a negative rate of return on their shares.
  • The Company has a limited public float, which adversely affects trading volume and liquidity, and may adversely affect the price of the Common Stock and access to additional capital.
  • There is no guarantee that the Warrants will ever be in the money, and they may expire worthless.
  • The Company may redeem unexpired Warrants prior to their exercise at a time that is disadvantageous to you, thereby making your Warrants worthless.

Future Outlook

The document outlines potential future actions related to the offering and sale of securities, but does not provide specific financial guidance.

Industry Context

The document does not provide specific industry context beyond the company's business description.

Stakeholder Impact

  • The resale of shares by selling securityholders could significantly decrease the trading price of the Common Stock, negatively impacting current shareholders.
  • The potential for the company to raise capital through warrant exercises could benefit the company and its stakeholders.

Next Steps

  • The selling securityholders may offer, sell or distribute all or a portion of their shares of Common Stock or Warrants publicly or through private transactions.
  • The company may use the net proceeds from any exercise of the existing Warrants for general corporate purposes.

Key Dates

DateDescription
March 11, 2021CF VIIIs initial public offering of CF VIII Units was consummated.
November 29, 2023We consummated the business combination (the Closing) pursuant to that certain Agreement and Plan of Merger, dated October 9, 2022.
January 31, 2024The closing price of our Common Stock was $2.26.
February 2, 2024Date of the preliminary prospectus.

Keywords

common stock, warrants, registration statement, selling securityholders, Sponsor, BTC International, resale, XBP Europe, securities, offering

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.